McMillan, A., Haioun, C., Sancho, J., Viardot, A., Rodriguez Izquierdo, A., Donato Martin, E. M., García-Sancho, A. M., Sandoval-Sus, J., Tilly, H., Vandenberghe, E., Hirata, J., Choudhry, P., Chang, Y. M., Musick, L., & Matasar, M. (n.d.). p1189: INITIAL SAFETY RUN-IN RESULTS OF THE PHASE III POLARGO TRIAL: POLATUZUMAB VEDOTIN PLUS RITUXIMAB, GEMCITABINE, AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA. HemaSphere, 6, 1075–1076. http://access.bl.uk/ark:/81055/vdc_100159757491.0x000005